Equities

InnoCare Optoelectronics Corp

6861:TAI

InnoCare Optoelectronics Corp

Actions
TechnologyTechnology Hardware and Equipment
  • Price (TWD)60.80
  • Today's Change-0.20 / -0.33%
  • Shares traded115.38k
  • 1 Year change-29.30%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

InnoCare Optoelectronics Corp is a Taiwan-based company engaged in the manufacture and sale of optoelectronic semiconductor components. The company is mainly engaged in the research and development (R&D), design and sales of X-ray flat panel sensor components and modules, and also provides assembly services for medical electronic components. The company's main products are key components for digital radiography (DR) systems using thin-film transistor-photodiode (TFT-PD) technology. The main product categories developed are X-ray flat panel sensor components and X-ray flat panel sensor modules. The company sells its products mainly in domestic and overseas markets, including Asia, America, Europe and other regions.

  • Revenue in TWD (TTM)1.88bn
  • Net income in TWD118.93m
  • Incorporated2019
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Excel Cell Electronic Co Ltd1.77bn32.62m2.44bn1.19k74.990.949211.921.380.29870.298716.2423.600.41583.925.54--0.79782.961.064.1213.5318.041.926.211.05--0.29673.22-19.28-2.48-78.98-26.651.12-25.28
InnoCare Optoelectronics Corp1.88bn118.93m2.46bn--21.441.8612.131.312.852.8544.9532.840.77662.512.95--4.92--8.41--27.00--6.33--1.68--0.1182---2.62---41.29------
Davicom Semiconductor Inc181.44m11.38m2.48bn90.00216.442.48126.8113.650.13770.13772.1912.010.16092.007.64--1.014.451.044.6266.6168.966.2720.1922.54--0.0676131.46-21.01-1.46-26.496.16-2.84-5.28
Abonmax Co Ltd336.95m-51.30m2.58bn303.00--7.54--7.66-0.8789-0.87895.774.010.5257.049.28---11.14-7.60-18.75-13.67-0.10099.36-21.23-8.062.09--0.3559---1.57-10.7551.09---19.07--
APCB INC5.76bn44.13m2.59bn4.83k59.080.71956.600.44960.27420.274236.0022.520.65987.853.51--0.50541.271.102.889.1811.710.7661.571.34--0.4794110.38-14.44-7.8055.72-37.19-15.55-27.52
Micro Silicon Electronics Co Ltd999.47m42.26m2.62bn--58.581.928.252.620.65120.651215.1519.840.458144.493.57--1.94--2.40--19.61--4.23--1.87--0.3253---26.23---115.61------
Data as of Nov 15 2024. Currency figures normalised to InnoCare Optoelectronics Corp's reporting currency: Taiwan Dollar TWD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.